NCT03887273 2023-08-21
Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis
Q Therapeutics, Inc.
Phase 1/2 Unknown
Q Therapeutics, Inc.
North Carolina State University
Office of Rare Diseases (ORD)